TC
Congress trade
Sen. Thomas Carper (D-DE) bought $1K-$15K of Intellia Therapeutics, Inc. (NTLA) stock
Thomas Carper, U.S. Senator (D-DE), disclosed a purchase of Intellia Therapeutics, Inc. (NTLA) stock worth $1K-$15K in a STOCK Act filing on Jun 30, 2023.
The trade happened on May 22, 2023, 39 days before it was made public.
NTLA has moved -72.4% since the trade date, from $44.39 to $12.26 (Oct 2, 2026 close).
- Traded
- May 22, 2023
- Disclosed
- Jun 30, 2023
- Filing delay
- 39 days
- Price since
- -72.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (5)
More NTLA insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.